Review
Copyright ©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 10-27
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.10
Figure 4
Figure 4 Clinical images of a “high-risk” cornea from a patient with ocular surface disease transplanted with a recombinant human collagen-based hydrogel. A: Corneal graft bed showing fluorescein stained epithelial erosion/ulcer (green/yellow staining) and vascularization before transplantation; B: Relatively clear cornea with clinically visible regression of peripheral corneal vessels 12 mo post-surgery[215].